Parents
Sign in to add mentor| Geoffrey K. Blair | fellowship/program director | 1993 | British Columbia Children's Hospital |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Holland CJ, Crean RM, Pentier JM, et al. (2020) Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA. The Journal of Clinical Investigation |
| Bossi G, Kenefeck R, Boudousquie CC, et al. (2016) Abstract 4873: ImmTACs re-direct the immune system efficiently to eradicate cancer Cancer Research. 76: 4873-4873 |
| Knox A, Chester F, Bianchi F, et al. (2016) Abstract 4872: Developing high affinity, soluble T cell receptors for the treatment of cancer Cancer Research. 76: 4872-4872 |
| Donnellan Z, Bossi G, Harper J, et al. (2015) ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing Journal For Immunotherapy of Cancer. 3: 299 |
| Bossi G, Baker D, Adams K, et al. (2014) Abstract 670: ImmTACs: Bi-specific TCR-anti-CD3 fusions for potent re-directed killing of cancer cells Cancer Research. 74: 670-670 |
| Hassan NJ, Bossi G, Baker D, et al. (2014) Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma Cancer Research. 74: 2900-2900 |
| Cameron BJ, Gerry AB, Dukes J, et al. (2013) Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells. Science Translational Medicine. 5: 197ra103 |
| Liddy N, Bossi G, Adams KJ, et al. (2012) Monoclonal TCR-redirected tumor cell killing. Nature Medicine. 18: 980-7 |
| Hassan NJ, Baker D, Harper J, et al. (2012) Abstract 3528: IMCmage1: A novel bi-specific biologic re-directing T cells to kill MAGE-A3/A6 presenting cancers Cancer Research. 72: 3528-3528 |
| Hassan NJ, Adams K, Bossi G, et al. (2012) Abstract 3525: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma Cancer Research. 72: 3525-3525 |